Novo Nordisk NVO ended its collaboration agreement with telehealth company Hims & Hers Health HIMS to offer its blockbuster ...

Mark Minervini shares what’s worked for him over his long trading career and talks about how to invest in the stock market ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

Focusing solely on achieving weight loss for people with a high body mass index (BMI) may do more harm than good, argue ...

W. Timothy Garvey, M.D., served as lead author in the clinical trial. A new combination drug therapy is showing extraordinary ...

Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped ...

Some supplements can support healthy weight loss, but they’re not a magic fix, says Raj Dasgupta, M.D., a quadruple board-certified internist at Huntington Health Hospital in Pasadena, California.

When you’re on the go, meal replacement shakes are quick and easy ways to satisfy your hunger. Here are the best meal replacement shakes for weight loss.

As GPs gain the right to prescibe weight loss jabs, a doctor shares the pros and cons of taking drugs like Ozempic, ... Now, for the first time, GPs are allowed to prescribe them.

Let's face it. Losing weight isn't easy, even if you're active or putting in hours at the gym. While cutting calories or spending time on the elliptical can help, there are options out there that ...

A GLP-1 in pill form from Eli Lilly shows promising results for weight loss and Type 2 diabetes treatment in a trial. FDA approval is expected in 2026.

Background Chronic inflammation and elevated reactive oxygen species are key contributors to hepatocellular carcinoma (HCC) ...